Term: | grazoprevir |
|
Accession: | CHEBI:132975
|
browse the term
|
Definition: | An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults. |
Synonyms: | exact_synonym: | (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide |
| related_synonym: | Formula=C38H50N6O9S; InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1; InChIKey=OBMNJSNZOWALQB-NCQNOWPTSA-N; MK 5172; SMILES=[C@@]1(C(NS(C2CC2)(=O)=O)=O)(C[C@H]1C=C)NC(=O)[C@H]3N4C[C@@H](C3)OC5=C(CCCCC[C@H]6[C@@H](C6)OC(N[C@H](C4=O)C(C)(C)C)=O)N=C7C(=N5)C=C(C=C7)OC |
| xref: | CAS:1350514-68-9; Drug_Central:5081; PMCID:PMC4135988; PMID:24666106; PMID:24727022; PMID:25266288; PMID:25467560; PMID:25467591; PMID:26353843; PMID:26423374; PMID:26532861; PMID:26682473; PMID:26818134; PMID:26849059; PMID:26926625; PMID:26933896; PMID:26938699; PMID:26943930; PMID:27091555; PMID:27123552; PMID:27291249; PMID:27403342; PMID:27418810; Reaxys:19999739; Wikipedia:Grazoprevir |
|
|